Biotonix (2010) Inc.

Biotonix (2010) Inc.

August 30, 2011 18:04 ET

Biotonix Announces Second Quarter 2011 Results

- Increase in sales compared to 2nd quarter of 2010

- Steady growth of the gross margin compared to the 2nd quarter 2010

BROSSARD, QUEBEC--(Marketwire - Aug. 30, 2011) - Biotonix (2010) Inc. (TSX VENTURE:BTX) a leader in postural health, today announced the financial results for the second quarter ended June 30, 2011. "During the quarter, we carried out mandates from large corporations which allowed us to further penetrate the corporate market. In addition, Biotonix seized the opportunity to introduce its portfolio to approximately twenty CEOs heading some of the largest fitness chains in Europe. This event thrust Biotonix into the limelight just as the Company is pursuing its sales efforts in a market with activities accounting for approximately US$20 billion annually" said Louise St-Onge, CEO of Biotonix.

"In addition, a slow penetration of target markets has prompted the Company to move forward with restructuring initiatives including personnel and wage cutbacks in order to preserve its cash flow. The Company also suspended its research and development activities", she added.


  • Biotonix posted a 27% increase in sales compared to the same period in 2010 due to mandates secured in the corporate solutions market and to an accounting change on a client contract.
  • Biotonix also achieved a 57% increase in gross profit compared to 42% at the same period in 2010 by securing mandates in the corporate market segment during the third quarter and by maintaining cost of sales.


Quarters ended June 30th Six months ended June 30th
Unaudited Unaudited
2011 2010 2011 2010
$ $
Statement of Operations
Sales 157,278 123,485 289,189 238,583
Gross margin 89,084 51,393 156,748 96,425
Net loss (341,761 ) (986,094 ) (857,834 ) (1,612,114 )
Net loss per share, basic and diluted (0.015 ) (0.022 ) (0.022 ) (0.030 )
Weighted average number of shares 23,188,667 23,094,167 23,094,167 21,035,000
Balance sheet
Cash flow and deposits 703,612 1,073,561 703,612 1,073,561
Total assets 1,044,972 1,758,506 1,044,972 1,758,506
Long-term debt including short-term portion



Total liabillities 503,149 450,376 503,149 450,376
Shareholder's equity 541,823 1,308,130 541,823 1,308,130

Revenues for the quarter reached $157,278 compared to $123,485 last quarter, a 27% increase. Mandates carried out in the corporate solutions market account for 61% of the increase, while accounting changes associated with a client contract account for the 39% balance.


On the basis of current projections and cash inflows from the private financings, management believes the Company will have sufficient funds available to support its activities for the current fiscal year. Accordingly, the Company must secure a financing, increase its sales or cut operating costs in order to pursue it activities.



Biotonix has developed a unique biomechanical evaluation system and method which is at the core of all its applications. The system helps health and fitness professionals to assess, improve and monitor posture and overall fitness. The Biotonix web-based imaging software system is easy to use, non-invasive and provides a complete individualized assessment of musculoskeletal form and function, postural deviation detection, and corresponding corrective exercises. To date, the Company has generated over 425,000 postural and fitness assessments, including over 1,000 world-class athletes and corporations form the Fortune 500.


Designed to meet the specific needs of the fitness market, FitPrint™ has the capability to assess posture as well as establish physiological age in order to improve muscular balance, performance and overall fitness, and rejuvenate the body.

Biotonix's is currently negotiating with major fitness organizations and several Fortune 500 companies.


More information is available on Biotonix's website at as well as on the SEDAR website at


Biotonix (TSX VENTURE:BTX) offers innovative health solutions for posture correction and fitness using a web-based imaging software technology. For more information please visit


This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. There is a risk that expectations and forward looking statements will not prove to be accurate. Readers are cautioned not to place undue reliance on these forward looking statements as they involve risks and uncertainties, which could make actual results differ materially from those projected herein and depend on a number of factors including, but not limited to, no history of profitability, future financing, intellectual property and patents, key personnel, competitive marketplace, technology obsolescence, share price volatility and other risks detailed in the Company's 2010 Management Discussion & Analysis. While Biotonix anticipates that subsequent events and developments may cause its views to change, Biotonix specifically disclaims any obligation to update these forward looking statements, unless obligated to do so by applicable securities laws.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information